title: Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES.
authors.affiliation: Department of Medicine at Stanford University School of Medicine, Calif, USA. salpeter@stanford.edu
authors.forename: Shelley R
authors.initials: SR
authors.lastname: Salpeter
mesh_terms: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D016265:Conflict of Interest; D000075202:Contraindications; D004341:Drug Evaluation; D006801:Humans; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
chemical_list: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists